Drug Shortage Report for CHORIONIC GONADOTROPIN FOR INJECTION, USP

Last updated on 2024-03-23 History
Report ID 220032
Drug Identification Number 02247459
Brand name CHORIONIC GONADOTROPIN FOR INJECTION, USP
Common or Proper name CHORIONIC GONADOTROPIN FOR INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CHORIONIC GONADOTROPIN
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 10000UNIT
ATC code G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-26
Estimated end date 2024-03-25
Actual end date 2024-03-22
Shortage status Resolved
Updated date 2024-03-23
Company comments We regret to advise that we will be experiencing a backorder on this product.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-03-23 English Compare
v5 2024-03-22 French Compare
v4 2024-03-22 English Compare
v3 2024-02-27 English Compare
v2 2024-02-20 French Compare
v1 2024-02-20 English Compare

Showing 1 to 6 of 6